Navigation Links
Single-celled bacterium works 24-7
Date:4/28/2008

search team examined the expression of 5,000 genes, measuring the amount of messenger RNA for each gene in alternating dark and light periods over 48 hours. At a given time, the mRNA levels indicated what the cells were doing. For example, when the researchers identified high levels of many mRNAs encoding various protein components of the nitrogenase enzyme, they knew that the cells were fixing nitrogen at that time, in this case, during the dark periods.

Of the 5,000 genes studied, nearly 30 percent cycled on and off with changing light and dark periods. These particular genes, the study found, also govern major metabolic processes. Therefore, the cycling of mRNA transcription, Pakrasi said, provides deep insight into the physiological behavior of the organism -- day and night.

During the day, Cyanothece busies itself with photosynthesis. Using energy from sunlight, carbon dioxide from the atmosphere, and water, Cyanothece produces glucose, a sugar it stores in glycogen granules, filling its chemical gas tank. At night, the Cyanothece ramps up production of nitrogenase to fix nitrogen, as expected. Since nitrogen fixation requires a lot of energy, Cyanothece uses the glycogen stored in its chemical gas tank through a process called respiration. Because respiration requires oxygen, the cells conveniently use up this by-product of photosynthesis, likely helping to protect nitrogenase from degradation.

Through this cyclic expression of genes, Cyanothece is essentially a living battery, storing energy from the sun for later use. This feat continues to elude scientists searching for ways to harness sunlight and produce energy on a large scale. With this in mind, a new project for the Pakrasi team seeks to use the machinery of Cyanothece -- its energy storage strategy, its anaerobic conditions that protect important enzymes -- as a biofactory to produce hydrogen from sunlight, the ultimate clean energy source.


'/>"/>

Contact: Gayle Geren
geren@wustl.edu
314-935-7163
Washington University in St. Louis
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Bacterium sequenced makes rare form of chlorophyll
2. Researchers decode genetics of rare photosynthetic bacterium
3. Rain forest protection works in Peru
4. MIT works toward safer gene therapy
5. IdentiPHI Re Launches SAFmodule Software to Secure Novell(R) Networks
6. IdentiPHI Re Launches SAFmodule Software to Secure Novell(R) Networks
7. Alternative food networks connect ethical producers and consumers and can lead to healthier eating
8. Workshops on biotechnology and water for science journalists
9. MIT works toward engineered blood vessels
10. Solidus Networks, Inc. Seats New Board of Directors
11. ESFs workshop restores good name of sugar
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2015)... , May 18, 2015 Fingerprint Cards ... FPC1020, FPC1025, FPC1145, FPC1155 and FPC1035 from one if its ... until and including Q3 2015 and the sensors will be ... Communicated order values for 2015 hereby amount to 740 MSEK ... 2015 of 140 MSEK and a number of smaller orders ...
(Date:5/14/2015)... , May 14, 2015  Verificient Technologies, ... verification and online remote proctoring, announced a ... (SaaS) company and creator of the Canvas ... the two companies will benefit from the ... As a fully integrated multifactor ...
(Date:5/11/2015)... , May 11, 2015  Through a well-rounded UAS delegation ... had a strong showing at AUVSI,s Unmanned 2015 conference ... of Ohio,s UAS industry met with ... from all points along the UAS ecosystem. ... (DDC) Vice President for Aerospace Rich Knoll . "If ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2
... free. But we'd all agree it's not worthless. So, ... , In 1997, the University of Vermont's Robert Costanza ... per year in a now-famous paper in the journal ... services" has bloomed. This young discipline studies how nature--through ...
... developed the first-ever genomic test to predict which patients ... and which patients can avoid the toxic regimen of ... save thousands of lives each year by recommending chemotherapy ... the test's developers at Duke's Institute for Genome Sciences ...
... therapy extends average life expectancy and decreases recurrences of ... lung cancer, according to researchers at Rhode Island Hospital. ... seven years, the median survival rate at three years ... months when thermal ablation was followed by radiation for ...
Cached Biology News:What's nature worth? New computer models tell all 2First-ever genomic test predicts which lung cancer patients need chemotherapy to live 2First-ever genomic test predicts which lung cancer patients need chemotherapy to live 3First-ever genomic test predicts which lung cancer patients need chemotherapy to live 4Combined treatment extends life expectancy for lung cancer patients 2Combined treatment extends life expectancy for lung cancer patients 3
(Date:6/1/2015)...  Berg, a biopharmaceutical company committed to uncovering health ... from its trials using its cancer drug BPM 31510 ... triple negative breast cancer, at the 51 st ... (ASCO), May 29 – June 2 in ... one of the first cancer drugs guided in development ...
(Date:6/1/2015)... Shire plc (LSE: SHP, NASDAQ: ... in the Jefferies 2015 Global Healthcare Conference in ... 2, 2015. Jeff Poulton , Chief Financial Officer ... 10:00 a.m. ET (3:00 p.m. BST). A ... and Webcasts section of Shire,s Investor website at ...
(Date:6/1/2015)... Research and Markets ( http://www.researchandmarkets.com/research/tdw3ss/2015_strategies ) ... Strategies in the UK Flow Cytometry Market" ... presents a comprehensive analysis of the UK flow ... to the French flow cytometry practice, as well ... trends with significant market impact during the next ...
(Date:6/1/2015)... 2015 Hutchison China MediTech ... AB (publ) ("AstraZeneca"), Hutchison MediPharma Limited,s ("HMP") collaboration ... Ib clinical trial of HMP,s c-Met inhibitor savolitinib ... non-small cell lung cancer ("NSCLC"). AZD9291 ... factor receptor (EGFR). Preliminary data on the activity ...
Breaking Biology Technology:Berg Presents Data On BPM 31510 Solid Tumor Trial At ASCO Annual Meeting That Reveals The Promise Of Metabolically Driven Therapy 2Berg Presents Data On BPM 31510 Solid Tumor Trial At ASCO Annual Meeting That Reveals The Promise Of Metabolically Driven Therapy 3Strategies in the UK Flow Cytometry Market 2015 2Savolitinib (AZD6094) Preliminary Phase Ib Clinical Data in Lung Cancer Presented at the 2015 ASCO Annual Meeting 2Savolitinib (AZD6094) Preliminary Phase Ib Clinical Data in Lung Cancer Presented at the 2015 ASCO Annual Meeting 3
... system, described as a breakthrough advancement in breast imaging, ... Drug Administration. , ,The system offers more evidence that ... tools that enable higher quality images for the detection ... GE Healthcare said the Senographe Essential system ...
... we asked William Yasnoff, founder of the eHealthTrust initiative, why ... that today are fractured and limited. , , ... William Yasnoff Yasnoff is a speaker at ... deliver a presentation titled "A New Patient-Centric and Sustainable Approach ...
... Madison, Wis. The Wisconsin Technology Council ... legislature with statewide membership arms, has announced eight additions ... have three-year terms and will join a board that ... business technology community. Electees include four technology organization leaders: ...
Cached Biology Technology:FDA approves advanced digital mammography system 2Interview: Dr. William Yasnoff on health records, part 2 2Interview: Dr. William Yasnoff on health records, part 2 3Interview: Dr. William Yasnoff on health records, part 2 4Interview: Dr. William Yasnoff on health records, part 2 5Interview: Dr. William Yasnoff on health records, part 2 6